Na Lu

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Breast Cancer Cells

Structure Activity Relationship

Top Venues

Journal of experimental & clinical cancer research : CR

Journal of cellular physiology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Jiaying Du, Dongsheng Bai, Chunyang Gu, Jiawei Zhao, Chen Zhou, Yuxiang Wang, Yue Zhao, Na Lu
Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism to evade its anti-hepatocellular carcinoma efficacy. Oncogene (2024)
Yongxu Li, Tiepeng Wang, Quan Wan, Qing Wang, Zhenzhong Chen, Yuan Gao, Yuchen Ye, Jiusheng Lin, Bihuan Zhao, Huaile Wang, Jinming Yang, Kai Zhao, Na Lu
TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance. Cancer research 82 (19) (2022)
Jiawei Zhao, Dongsheng Bai, Lei Qi, Wangjia Cao, Jiaying Du, Chunyang Gu, Chen Zhou, Yuan Gao, Lulu Zhang, Yue Zhao, Na Lu
GL-V9 alleviates liver fibrosis via triggering GATA4-mediated senescence in activated hepatic stellate cells. British journal of pharmacology (2022)
Yue Zhao, Dongsheng Bai, Jiaying Du, Haochuan Ren, Zhenguo Zhang, Cheng Jiang, Na Lu
Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma. Cell biology and toxicology 37 (1) (2020)
Dawei Yang, Qinglong Guo, Yin Liang, Yue Zhao, Xiaoyu Tian, Yuchen Ye, Jieyi Tian, Tao Wu, Na Lu
Wogonin induces cellular senescence in breast cancer via suppressing TXNRD2 expression. Archives of toxicology 94 (10) (2020)
Binyan Lin, Yongxu Li, Tiepeng Wang, Yangmin Qiu, Zhenzhong Chen, Kai Zhao, Na Lu
CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK. Oncogene 39 (37) (2020)
Chuyue Pan, Qinglong Guo, Na Lu
Role of Gut Microbiota in the Pharmacological Effects of Natural Products. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)
Yuyuan Yao, Qinglong Guo, Yue Cao, Yangmin Qiu, Renxiang Tan, Zhou Yu, Yuxin Zhou, Na Lu
Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer. Journal of experimental & clinical cancer research : CR 37 (1) (2018)
Binyan Lin, Kai Zhao, Dawei Yang, Dongsheng Bai, Yan Liao, Yuxin Zhou, Zhou Yu, Xiaoxuan Yu, Qinglong Guo, Na Lu
Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis. Journal of cellular physiology 234 (2) (2018)
Yuan Gao, Dongsheng Bai, Yue Zhao, Qin Zhu, Yihui Zhou, Zhiyu Li, Na Lu
LL202 ameliorates colitis against oxidative stress of macrophage by activation of the Nrf2/HO-1 pathway. Journal of cellular physiology 234 (7) (2018)
Yuyuan Yao, Kai Zhao, Zhou Yu, Haochuan Ren, Li Zhao, Zhiyu Li, Qinglong Guo, Na Lu
Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer. Journal of experimental & clinical cancer research : CR 36 (1) (2017)